%0 Journal Article
%T Research on Effects of Comorbidities Disease on Anticoagulation and Bleeding Disorders Risk in Patients with Overdosage of Vitamin K Antagonist Anticoagulant
%A Si Dung Chu
%A Minh Thi Tran
%J Open Journal of Emergency Medicine
%P 68-79
%@ 2332-1814
%D 2023
%I Scientific Research Publishing
%R 10.4236/ojem.2023.113008
%X <strong>Objectives:</strong> Research on effects of comorbidities disease on anticoagulation overdose in patients receiving anticoagulant therapy with vitamin K antagonists anticoagulant (VKAs) drugs at HaiPhong-VinhBao International General Hospital. <strong>Methods:</strong> Description and Prospective study. Research on 79 patients receiving anticoagulant therapy with VKAs who have an INR testing index of more than anticoagulation dose with VKAs and check INR every 4 weeks.<strong> Results:</strong> The average research age is 65.65 ¡À 12.17 years [33: 85], most of the elderly group. The Male group is lower than the female group (p &gt; 0.05). Patients with hemorrhage signs account for 22.8%. The INR testing index has an average value is 5.88 ¡À 3.0 [3.02 - 23.95]; The group of INR &gt; 5 level is a higher risk of bleeding than the group of INR ¡Ü 5 levels, there is statistical difference (p &lt; 0.001). Patients using anti-vitamin K drugs on the background of patients with many complicated conditions are easily at risk of bleeding, especially in patients with renal falure and musculoskeletal disease are the cause of the increased risk of bleeding with the rate of the difference is OR = 3.64 (CI: 1.17 - 11.32, with p &lt; 0.05) and OR = 3.52 (CI: 1.19 - 10.47, with p &lt; 0.05) of statistical significance. <strong>Conclusion:</strong> All most patients with anticoagulation overdose are in the elderly group. The group with INR &gt; 5 levels has a higher risk of bleeding than the group with INR ¡Ü 5 levels, it¡¯s the statistical significance (p &lt; 0.001). The comorbidities Diseases such as hypertension, ischemic heart disease, coronary stents, old myocardial infarction, Graves, and gastritis all have the risk of increasing the risk of bleeding when taking anticoagulants but not yet statistically significant (have OR &gt; 1 but p &gt; 0.05); Patients used VKAs drugs on the background of kidney failure or arthritis pathology are the cause of the increased risk of bleeding, it¡¯s statistical significance (p &lt; 0.05).
%K Comorbidities Disease
%K INR
%K VKAs
%K Bleeding Disorders
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=127601